ArticleAnnals of work exposures and health2026
Descriptive analysis of exposure levels of organophosphate esters among firefighters, paramedics, and office workers.
Article in Annals of work exposures and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundOrganophosphate esters (OPEs) are a class of chemicals used as flame retardants and plasticizers in many products and industries. While research shows that OPE exposure is widespread in the general population, studies on the working population are scarce, despite their potential of being at higher risk of exposure due to their handling of OPE containing materials and products across their lifecycle.
objectivesThis study aims to characterize OPE exposure among firefighters, paramedics, and office workers, to describe internal exposure levels, evaluate changes over a 24-h period including a work shift, and determine whether levels differ between occupational groups.
methodsParticipants provided two spot urine samples over the sampling period; one at the beginning of their shift (day 1) and another after 24 h (day 2). Twelve urinary OPE metabolites (mOPEs) were quantified. mOPE levels were described, and differences between groups and changes over time were examined using ANOVA and bivariate statistics.
resultsForty firefighters, 12 paramedics, and 13 office workers participated (78.5% male; mean age = 41 years). The highest geometric mean (GM) concentrations were observed for diphenyl phosphate (DPhP) (day 1: 1.09 µg/g-creatinine [GSD: 2.38], day 2: 1.20 µg/g-creatinine [GSD: 2.22]) and bis (1,3-dichloro-2-propyl) phosphate (BDCIPP) (day 1: 0.91 µg/g-creatinine [GSD: 3.04], day 2: 0.84 µg/g-creatinine [GSD: 3.17]). BDCIPP GM levels were significantly higher among firefighters (day 1: 1.25 µg/g-creatinine, day 2: 1.09 µg/g-creatinine; P-values < 0.001) and paramedics (day 1: 1.15 µg/g-creatinine, day 2: 1.23 µg/g-creatinine: P-values < 0.01) compared with office workers. While firefighters tended to have higher levels of mOPEs than other groups, not all differences reached statistical significance. Office workers tended to have higher DPhP levels than paramedics (day 1: office workers: 1.13 µg/g-creatinine, paramedics: 0.79 µg/g-creatinine, P = 0.565; day 2: office workers: 1.05 µg/g-creatinine, paramedics: 0.78 µg/g-creatinine, P = 0.597).
conclusionsOur results confirm consistent exposure to a subset of measured OPEs among these occupational groups. Concentrations of BDCIPP differed across occupations, suggesting potential exposure to different sources in those workplaces. However, the personal and work-related factors that contribute to these differences remain unclear. Given the concerns regarding possible adverse health effects related to OPE exposure (eg TDCIPP), more effort is needed to identify determinants and reduce occupational exposure to OPEs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.